

BARNALY (Social Change for Sustainable Development) is a non-government, Socio- economic development organization in Chattogram. Chattagrom being the port city and commercial capital city of Bangladesh, substantial number of people is under the marginal level in Chittagong division particularly, for lack of knowledge and practices of modern life. To address this situation, a group of progressive youths took initiative to form a youth group in March 26, 1997. The ultimate outcome of the initiative is BARNALY which began its course of participation in the development process. Since its inception, Barnaly has played an important role to protect socio-economic hazards by initiating and implementing various social development and environment development interventions. Barnaly has been endeavoring its best to organize the target groups through alliance and consistency, and have made them involved in the mainstream of development process. Involvement of community and local stakeholders are the key to have long term impact of this activates. BARNALY has mobilized to community and youth on making advocacy with local government to continue the services of Hepatitis A,B,C,D . BARNALY will make a linkage this Activates to another project of BARNALY. In addition to adopting relevant knowledge and capacity development from YOU, we want to more exposure and learning from this International networks.
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close